These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27089987)

  • 1. Overcoming treatment resistance in cancer: Current understanding and tactics.
    Wu G; Wilson G; George J; Liddle C; Hebbard L; Qiao L
    Cancer Lett; 2017 Feb; 387():69-76. PubMed ID: 27089987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
    Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
    Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of Notch Signaling Pathway as an Effective Chemosensitizer for Cancer Treatment.
    Majidinia M; Alizadeh E; Yousefi B; Akbarzadeh M; Zarghami N
    Drug Res (Stuttg); 2016 Nov; 66(11):571-579. PubMed ID: 27701712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
    Mittal V
    Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
    Garg M
    Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition.
    Goldman A; Majumder B; Dhawan A; Ravi S; Goldman D; Kohandel M; Majumder PK; Sengupta S
    Nat Commun; 2015 Feb; 6():6139. PubMed ID: 25669750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of cisplatin resistance in bladder cancer.
    Drayton RM; Catto JW
    Expert Rev Anticancer Ther; 2012 Feb; 12(2):271-81. PubMed ID: 22316374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
    Mitra A; Mishra L; Li S
    Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment and cancer therapy resistance.
    Sun Y
    Cancer Lett; 2016 Sep; 380(1):205-15. PubMed ID: 26272180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
    Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
    Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pathways: Targeting Cancer Stem Cells Awakened by Chemotherapy to Abrogate Tumor Repopulation.
    Chan KS
    Clin Cancer Res; 2016 Feb; 22(4):802-6. PubMed ID: 26671994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy in cancer and chemotherapy.
    Yousefi S; Simon HU
    Results Probl Cell Differ; 2009; 49():183-90. PubMed ID: 19142622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF inhibitors in cancer therapy.
    Hertzman Johansson C; Egyhazi Brage S
    Pharmacol Ther; 2014 May; 142(2):176-82. PubMed ID: 24325952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in therapy for solid tumors: potential for overcoming drug resistance in vivo with molecular targeting agents.
    Kim R; Toge T
    Surg Today; 2004; 34(4):293-303. PubMed ID: 15052442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the Discovery of Novel Therapeutic Agents in Cancer.
    Nagaraju GP; Kamal MA
    Curr Drug Metab; 2019; 20(12):931-932. PubMed ID: 31989914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming drug resistance to receptor tyrosine kinase inhibitors: Learning from lung cancer.
    Kuwano M; Sonoda K; Murakami Y; Watari K; Ono M
    Pharmacol Ther; 2016 May; 161():97-110. PubMed ID: 27000770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of signal transduction in cancer treatment and drug resistance.
    Liem AA; Chamberlain MP; Wolf CR; Thompson AM
    Eur J Surg Oncol; 2002 Sep; 28(6):679-84. PubMed ID: 12359208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.